---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-292616"
form_type: "8-K"
ticker: null
cik: "0001478069"
company_name: "CONTRAFECT Corp"
filed_at: "2022-11-25T23:59:59+00:00"
generated_at: "2026-06-21T13:02:47.168029+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# ContraFect gets Nasdaq deficiency letter; equity -$3.1M vs $2.5M minimum; bid price still deficient

## Summary
- Stockholders' equity as of Sept 30, 2022 was $(3.1M), below Nasdaq's $2.5M continued listing requirement.
- Company has 45 days (until Jan 6, 2023) to submit a plan to regain compliance with Nasdaq Rule 5550(b)(1).
- Prior bid price deficiency from Aug 25, 2022 (below $1.00 for 30 days) remains uncured.
- If plan is accepted, Nasdaq may grant up to 180 days (to May 21, 2023) to show compliance.
- No immediate effect on trading; company evaluating options but no assurance of regaining compliance.

## SEC filing metadata
- accession: 0001193125-22-292616
- form_type: 8-K
- cik: 0001478069
- company_name: CONTRAFECT Corp
- filed_at: 2022-11-25T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1478069/000119312522292616/0001193125-22-292616-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1478069/000119312522292616/d421710d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-292616
- JSON: https://secwatch.observer/filing/0001193125-22-292616.json
- Plain text: https://secwatch.observer/filing/0001193125-22-292616.txt

## Key facts
- Listing & Compliance Notices
  CONTRAFECT Corp received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: a listed company’s stockholders’ equity be at least $2.5 million. As reported on its Form 10-Q, the Company’s stockholders’ equity as of September 30, 2022 was approximately $(3.1) million. The Nasdaq Staff Deficiency Letter has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market which currently trades
  evidence_url: https://www.sec.gov/Archives/edgar/data/1478069/000119312522292616/0001193125-22-292616-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.